Bertram Wiedenmann

45.1k total citations · 9 hit papers
512 papers, 31.4k citations indexed

About

Bertram Wiedenmann is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Bertram Wiedenmann has authored 512 papers receiving a total of 31.4k indexed citations (citations by other indexed papers that have themselves been cited), including 233 papers in Epidemiology, 231 papers in Oncology and 125 papers in Neurology. Recurrent topics in Bertram Wiedenmann's work include Neuroendocrine Tumor Research Advances (193 papers), Lung Cancer Research Studies (128 papers) and Neuroblastoma Research and Treatments (124 papers). Bertram Wiedenmann is often cited by papers focused on Neuroendocrine Tumor Research Advances (193 papers), Lung Cancer Research Studies (128 papers) and Neuroblastoma Research and Treatments (124 papers). Bertram Wiedenmann collaborates with scholars based in Germany, United States and Italy. Bertram Wiedenmann's co-authors include Werner W. Franke, Guido Rindi, Stefan Rosewicz, Anne Couvelard, Philippe Ruszniewski, Axel Dignaß, Ursula Plöckinger, Ulrich‐Frank Pape, Katharina Detjen and Michael Höcker and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Bertram Wiedenmann

505 papers receiving 30.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

2011 1.8k citations Éric Raymond, Catherine Lombard‐Bohas et al. profile →
Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles

1985 1.3k citations Bertram Wiedenmann et al. profile →
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system

2006 1.2k citations Guido Rindi, Martyn Caplin et al. profile →
A colorectal cancer classification system that associates cellular phenotype and responses to therapy

2013 721 citations Anguraj Sadanandam, Costas A. Lyssiotis et al. profile →
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system

2007 693 citations Guido Rindi, Günter Klöppel et al. profile →
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary

2012 616 citations Éric Baudin, Anne Couvelard et al. Neuroendocrinology profile →
Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial

2009 487 citations James C. Yao, Catherine Lombard‐Bohas et al. Journal of Clinical Oncology profile →
ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas

2016 403 citations Rocio García‐Carbonero, Halfdan Sørbye et al. Neuroendocrinology profile →
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging

2017 303 citations Anders Sundin, Éric Baudin et al. Neuroendocrinology profile →

Peers

Countries citing papers authored by Bertram Wiedenmann

Since Specialization

Citations

This map shows the geographic impact of Bertram Wiedenmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertram Wiedenmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertram Wiedenmann more than expected).

Fields of papers citing papers by Bertram Wiedenmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertram Wiedenmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertram Wiedenmann. The network helps show where Bertram Wiedenmann may publish in the future.

Co-authorship network of co-authors of Bertram Wiedenmann

This figure shows the co-authorship network connecting the top 25 collaborators of Bertram Wiedenmann. A scholar is included among the top collaborators of Bertram Wiedenmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertram Wiedenmann. Bertram Wiedenmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	External low energy electromagnetic fields affect heart dynamics: surrogate for system synchronization, chaos control and cancer patient’s health 2025 ·PubMed ·Frederico Costa, Jack A. Tuszyński, Antônio Francisco Iemma, (unknown), Bertram Wiedenmann, Eckehard Schöll	1
2	Elevated sortilin expression discriminates functional from non-functional neuroendocrine tumors and enables therapeutic targeting 2024 ·Frontiers in Endocrinology ·Felix Bolduan, (unknown), (unknown), (unknown), Natália Alenina, Michael Bäder, Thomas E. Willnow, Bertram Wiedenmann, Michael Sigal	0
3	Emerging cancer therapies: targeting physiological networks and cellular bioelectrical differences with non-thermal systemic electromagnetic fields in the human body – a comprehensive review 2024 ·SHILAP Revista de lepidopterología ·Frederico Costa, Bertram Wiedenmann, Eckehard Schöll, Jack A. Tuszyński	5
4	High rate of Ki‐67 increase in entero‐pancreatic NET relapses after surgery with curative intent 2022 ·Journal of Neuroendocrinology ·Elettra Merola, Aurel Perren, Anja Rinke, Alessandro Zerbi, Mairéad G. McNamara, Ruža Arsenić, Nicola Fazio, Wouter W. de Herder, Juan W. Valle, Thomas M. Gress, Bertram Wiedenmann, Andreas Pascher, Marianne Pavel	9
5	ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours 2021 ·Journal of Neuroendocrinology ·Rodney J. Hicks, Clarisse Dromain, Wouter W. de Herder, Frederico Costa, Christophe M. Deroose, Andrea Frilling, Anna Koumarianou, Eric P. Krenning, Éric Raymond, Lisa Bodei, Halfdan Sørbye, Staffan Welin, Bertram Wiedenmann, Damian Wild, James R. Howe, James C. Yao, Dermot O’Toole, Anders Sundin, Vikas Prasad	13
6	Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms 2021 ·Cancers ·Katharina Detjen, (unknown), (unknown), Lukas Geisler, Pamela Riemer, Henning Jann, Carsten Grötzinger, Christine Sers, Andreas Pascher, Tom Lüdde, Ulf Leser, Bertram Wiedenmann, Michael Sigal, Frank Tacke, Christoph Roderburg, Linda Hammerich	6
7	Primary Neuroendocrine Neoplasms of the Breast: Case Series and Literature Review 2020 ·Cancers ·Burcin Özdirik, Antonin Kayser, (unknown), Lynn Jeanette Savic, Markus Reiß, Frank Tacke, Bertram Wiedenmann, Henning Jann, Christoph Roderburg	22
8	Diagnostic and therapeutic single-operator cholangiopancreatoscopy with SpyGlassDS™: results of a multicenter retrospective cohort study 2018 ·Surgical Endoscopy ·(unknown), (unknown), Arno J. Dormann, (unknown), Ralf Jakobs, Uwe Gottschalk, (unknown), Dirk Hartmann, (unknown), Frank T. Kolligs, W Veltzke-Schlieker, Andreas Adler, (unknown), Bertram Wiedenmann, (unknown), Hanno Tröger, Michael Schümann, S Daum, Britta Siegmund, Christian Bojarski	47
9	ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas breakdown → 2016 ·Neuroendocrinology ·Rocio García‐Carbonero, Halfdan Sørbye, Éric Baudin, Éric Raymond, Bertram Wiedenmann, Bruno Niederle, Eva Sedláčková, Christos Toumpanakis, Martin Anlauf, Jarosław B. Ćwikła, Martyn Caplin, Dermot O’Toole, Aurel Perren, (unknown)	403
10	A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics 2015 ·Cancer Discovery ·Anguraj Sadanandam, Stephan Wullschleger, Costas A. Lyssiotis, Carsten Grötzinger, Stefano Barbi, Samantha Bersani, (unknown), (unknown), Andrea Mafficini, Rita T. Lawlor, Michele Simbolo, John M. Asara, Hendrik Bläker, Lewis C. Cantley, Bertram Wiedenmann, Aldo Scarpa, Douglas Hanahan	139
11	Axon Guidance Factor SLIT2 Inhibits Neural Invasion and Metastasis in Pancreatic Cancer 2014 ·Cancer Research ·(unknown), Katharina Detjen, Georg Hilfenhaus, (unknown), Martina Welzel, Ruža Arsenić, Rosa Schmuck, Marcus Bahra, Jane Y. Wu, Bertram Wiedenmann, Christian Fischer	94
12	Glucocorticoids regulate barrier function and claudin expression in intestinal epithelial cells via MKP-1 2013 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Andréas Fischer, (unknown), Friderike Weege, Ulrich‐Frank Pape, Bertram Wiedenmann, Daniel C. Baumgart, Franz Theuring	71
13	1304 TH2 CYTOKINE-MEDIATED BILIARY EPITHELIAL CELL (BEC) BARRIER DYSFUNCTION MAY CONTRIBUTE TO IMMUNOGLOBULIN G4 (IGG4) ASSOCIATED SCLEROSING CHOLANGITIS (IAC) 2011 ·Journal of Hepatology ·Thomas Müller, (unknown), Alexandre Pico, Eric M. Schott, Andrea Fischer, Andreas Pascher, P. Neuhaus, Bertram Wiedenmann, Thomas Berg	1
14	Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial breakdown → 2009 ·Journal of Clinical Oncology ·James C. Yao, Catherine Lombard‐Bohas, Éric Baudin, Larry K. Kvols, Philippe Rougier, Philippe Ruszniewski, Sakina Hoosen, J. Peter, T Haas, David Lebwohl, Eric Van Cutsem, Matthew H. Kulke, Timothy J. Hobday, Thomas M. O’Dorisio, Manisha H. Shah, Guillaume Cadiot, Gabriele Luppi, James Posey, Bertram Wiedenmann	487
15	Antireflux ‘barriers’: problems with patient recruitment for a new endoscopic antireflux procedure 2009 ·European Journal of Gastroenterology & Hepatology ·Alexander J. Eckardt, (unknown), Heiko Pohl, Bertram Wiedenmann, Thomas Rösch	3
16	Systematic High-Content Proteomic Analysis Reveals Substantial Immunologic Changes in Colorectal Cancer 2008 ·Cancer Research ·Uta Berndt, Lars Philipsen, (unknown), Bertram Wiedenmann, Daniel C. Baumgart, (unknown), Andreas Sturm	20
17	Hypoxia-Inducible Factor 1α Mediates Anoikis Resistance via Suppression of α5 Integrin 2008 ·Cancer Research ·Nadine Rohwer, Martina Welzel, (unknown), David Pfander, Bertram Wiedenmann, Katharina Detjen, Thorsten Cramer	87
18	ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic Stratification 2008 ·Neuroendocrinology ·Günter Klöppel, Anne Couvelard, Aurel Perren, Paul Komminoth, Anne‐Marie McNicol, Ola Nilsson, Aldo Scarpa, Jean‐Yves Scoazec, Bertram Wiedenmann, Mauro Papotti, Guido Rindi, Ursula Plöckinger, (unknown)	247
19	73 A MULTICENTER ANALYSIS OF ANTIVIRAL RESPONSE AFTER ONE YEAR OF TENOFOVIR MONO-THERAPY IN HBV-MONOINFECTED PATIENTS WITH PRIOR NUCLEOS(T)IDE ANALOG EXPERIENCE 2008 ·Journal of Hepatology ·(unknown), Robert A. de Man, Kerstin Stein, (unknown), J. Petersen, Peter Buggisch, H. Wedemeyer, C. Sarrazin, Jörg Trojan, (unknown), Andreas Erhardt, Ulrich Spengler, Jurriën G.P. Reijnders, (unknown), (unknown), Bertram Wiedenmann, Thomas Berg	18
20	ClC-3 expression enhances etoposide resistance by increasing acidification of the late endocytic compartment 2007 ·Molecular Cancer Therapeutics ·Karsten H. Weylandt, (unknown), (unknown), Joanna S. Amey, David Carmena, Bertram Wiedenmann, Christopher F. Higgins, Alessandro Sardini	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact